Department of Radiation Oncology, Xijing Hospital, The Air Force Medical University, Xi'an, 710032, China.
Department of Chemistry, School of Pharmacy, The Air Force Medical University, Xi'an, 710032, China.
Mol Cancer. 2024 Oct 19;23(1):234. doi: 10.1186/s12943-024-02142-4.
Normal tissue and immune organ protection are critical parts of the tumor radiation therapy process. Radiation-induced immune organ damage (RIOD) causes several side reactions by increasing oxidative stress and inflammatory responses, resulting in unsatisfactory curability in tumor radiation therapy. The aim of this study was to develop a novel and efficient anti irradiation nanoparticle and explore its mechanism of protecting splenic tissue from radiation in mice.
Nanoparticles of triphenylphosphine cation NIT radicals (NPs-TPP-NIT) were prepared and used to protect the spleens of mice irradiated with X-rays. Splenic tissue histopathology and hematological parameters were investigated to evaluate the protective effect of NPs-TPP-NIT against X-ray radiation. Proteomics was used to identify differentially expressed proteins related to inflammatory factor regulation. In addition, in vitro and in vivo experiments were performed to assess the impact of NPs-TPP-NIT on radiation therapy.
NPs-TPP-NIT increased superoxide dismutase, catalase, and glutathione peroxidase activity and decreased malondialdehyde levels and reactive oxygen species generation in the spleens of mice after exposure to 6.0 Gy X-ray radiation. Moreover, NPs-TPP-NIT inhibited cell apoptosis, blocked the activation of cleaved cysteine aspartic acid-specific protease/proteinase, upregulated the expression of Bcl-2, and downregulated that of Bax. We confirmed that NPs-TPP-NIT prevented the IKK/IκB/NF-κB activation induced by ionizing radiation, thereby alleviating radiation-induced splenic inflammatory damage. In addition, when used during radiotherapy for tumors in mice, NPs-TPP-NIT exhibited no significant toxicity and conferred no significant tumor protective effects.
NPs-TPP-NIT prevented activation of IKK/IκB/NF-κB signaling, reduced secretion of pro-inflammatory factors, and promoted production of anti-inflammatory factors in the spleen, which exhibited radiation-induced damage repair capability without diminishing the therapeutic effect of radiation therapy. It suggests that NPs-TPP-NIT serve as a potential radioprotective drug to shelter immune organs from radiation-induced damage.
保护正常组织和免疫器官是肿瘤放射治疗过程中的关键环节。辐射诱导的免疫器官损伤(RIOD)通过增加氧化应激和炎症反应导致几种不良反应,从而导致肿瘤放射治疗的治愈率不理想。本研究旨在开发一种新型有效的抗辐射纳米颗粒,并探索其在保护小鼠脾脏组织免受辐射的机制。
制备三苯基膦阳离子 NIT 自由基纳米颗粒(NPs-TPP-NIT)并用于保护 X 射线照射的小鼠脾脏。通过评估 NPs-TPP-NIT 对 X 射线辐射的保护作用,研究了脾脏组织的组织病理学和血液学参数。采用蛋白质组学方法鉴定与炎症因子调节相关的差异表达蛋白。此外,进行了体外和体内实验以评估 NPs-TPP-NIT 对放射治疗的影响。
NPs-TPP-NIT 增加了暴露于 6.0Gy X 射线辐射后的小鼠脾脏中超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶的活性,并降低了丙二醛水平和活性氧的产生。此外,NPs-TPP-NIT 抑制了细胞凋亡,阻断了半胱氨酸天冬氨酸特异性蛋白酶/蛋白酶的切割激活,上调了 Bcl-2 的表达,并下调了 Bax 的表达。我们证实,NPs-TPP-NIT 防止了电离辐射诱导的 IKK/IκB/NF-κB 激活,从而减轻了辐射引起的脾脏炎症损伤。此外,当在小鼠肿瘤放射治疗期间使用时,NPs-TPP-NIT 没有表现出明显的毒性,也没有赋予明显的肿瘤保护作用。
NPs-TPP-NIT 防止了 IKK/IκB/NF-κB 信号的激活,减少了促炎因子的分泌,并促进了抗炎因子在脾脏中的产生,从而表现出辐射诱导的损伤修复能力,而不会降低放射治疗的治疗效果。这表明 NPs-TPP-NIT 可作为一种潜在的放射保护药物,使免疫器官免受辐射损伤。